Immunotherapy for Infectious Diseases

Immunotherapy for Infectious Diseases Immunotherapy for Infectious Diseases

ibvacunas.com
from ibvacunas.com More from this publisher
10.02.2013 Views

Cytokines, Cytokine Antagonists, and Growth Factors 119 cytokine to its soluble receptor prevents the cytokine from effecting target cell function. An analogous approach toward inhibiting cytokine effect by ligand binding may be used by some viruses that code for receptor-like molecules, e.g., IFN-� (7) and TNF-� (8), thereby inhibiting the effects of these cytokines on the host cell. Receptor Families Cytokine receptors are membrane glycoproteins with a single transmembrane domain and an external amino terminus. The functional receptor can consist of two or more subunits, and these subunits can be shared among different cytokines. This sharing of the receptor subunits among different cytokines may partially explain some of the functional redundancy and costimulation of their production and activity. The receptors can be grouped into four families according to similarities in their DNA or amino acid sequences: the cytokine receptor superfamily, the TNF superfamily, the immunoglobulin superfamily, and the IFN-R family. Most cytokine receptors are members of the cytokine receptor superfamily which is characterized by a conserved amino acid motif in the extracellular portion and in a region proximal to the membrane (9, 10). This superfamily can be divided into three subfamilies according to a shared subunit, i.e., those receptors that share the � chain, the gp 140 � chain, and the gp 130. The receptors in the � chain subfamily consist of three subunits (�, �, �): the �, and � subunits are members of the superfamily and are constitutively expressed on T-cells. Heterodimerization of the �� chains mediates signal transduction. The receptors for IL-13, IL-4, IL-7, IL-9, and IL-15 are members of this subfamily. An example of the sharing of the subunits of the cytokine receptor is the IL-2 receptor: IL-2R� is shared by IL-15, and IL-2R� is a subunit of the receptors for IL-4, IL-7, and IL-9. The subfamily of receptors that share the gp 140 � chain includes the receptors for IL-3, IL-5, and GM-CSF. Receptors in this subfamily have two subunits, with the � chain distinct for each receptor. Both the � and � chains are members of the cytokine receptor superfamily, and signaling is mediated through ligand interactions of the cytoplasmic regions on the shared � chain. The subfamily that shares gp 130 includes receptors for IL-6, IL-11, and IL-12. Formation of homodimers and heterodimers with gp 130 mediates signal transduction by these receptors. The TNF family of receptors includes two distinct receptors that bind TNF, TNFR- I (p75), and TNFR-II (p55). These receptors are homologous and bind both TNF-� and TNF-� with comparable affinity. Interestingly, other receptors in the TNF superfamily do not bind cytokines, e.g., FAS (CD95), which signals apoptosis of thymocytes (11) and CD40 ligand, which signals B-cell survival, proliferation, and switch in the Ig isotype (12). The immunoglobulin superfamily of receptors includes the two receptors for IL-1 (13). Although both receptors bind IL-1 well, the type I receptor is the active moiety, and the type II receptor appears to have minimal activity. However, the type II receptor may be the precursor for soluble IL-1 receptor, which can bind IL-1 after being shed from the membrane. A newly described member of the IL-1 receptor family is the receptor for IL-18, which contains a binding and signaling chain that appears to share signal transduction pathways similar to those of IL-1R (14). Members of the IFN-R family include the receptors for IFN-�, IFN-�, and IL-10, which are distant members of the cytokine receptor superfamily. Investigation into the method of gene transcription through signal transduction from the IFN receptors has become a model for signal transduction by several cytokines, i.e., the Jak-Stat paradigm.

120 Matthews Table 1 Source and Activity of Interleukins and Cytokines with a Major Role in Infection Cytokine Source Activity IL-1�, IL-1� Macrophages, B-cells Stimulates macrophages (increases production of IL-6, TNF-�); enhances PMN adhesion; activates lymphocyte increases IL-2); induces acute-phase protein production; enhances production of platelet-activating factor and nitric oxide IL-2 T-cells Promotes growth and differentiation of T-cells; enhances cytotoxicity of T-cells and NK cells IL-3 T-cells, stem cells Multilineage colony-stimulating factor (stem cells, erythroid, and myeloid) IL-4 T-cells, B-cells, monocytes, Suppresses production of IL-1, TNF, and mast cells, endothelial IFN-� (Th1); upregulates IL-1ra cells production; enhances Th2; promotes Band cytotoxic T-cells; increases IgG1 and IgE production; enhances MHC class II and IgE receptor function IL-5 T-lymphocytes Promotes proliferation and differentiation of B-cells and eosinophils; increases IgA production IL-6 T- and B-cells, NK cells, Activates T- and NK cells; induces monocytes, macrophages, immunoglobulin synthesis by B-cells; fibroblasts induces acute-phase protein synthesis by liver IL-7 Stromal cells of bone Induces proliferation of T- and B-cells marrow IL-8 Most cells including Causes leukocyte chemotaxis, enhances leukocyte and myeloid neutrophil adherence and degranulation precursors, endothelial cells, fibroblasts IL-9 T-cells Prolongs T-cell survival; activates mast cells IL-10 T-cells Inhibits cytokine production by Th1 (TNF-� and IL-1); upregulates IL-1ra production IL-11 Stromal cells of bone Inhibits proinflammatory cytokine marrow production; stimulates osteoclasts and CSF IL-12 Macrophages, dendritic Induces production of TH1 cells; enhances cells, B-cells, mast cells IFN-� production; induces proliferation of NK cells IL-13 T-cells Induces proliferation and differentiation of B-cells; enhances IgE and IgG4 production; inhibits production of proinflammatory cytokines IL-14 T-cells Induces proliferation of activated B-cells; inhibits secretion of immunoglobulin

Cytokines, Cytokine Antagonists, and Growth Factors 119<br />

cytokine to its soluble receptor prevents the cytokine from effecting target cell function.<br />

An analogous approach toward inhibiting cytokine effect by ligand binding may<br />

be used by some viruses that code <strong>for</strong> receptor-like molecules, e.g., IFN-� (7) and<br />

TNF-� (8), thereby inhibiting the effects of these cytokines on the host cell.<br />

Receptor Families<br />

Cytokine receptors are membrane glycoproteins with a single transmembrane domain<br />

and an external amino terminus. The functional receptor can consist of two or more<br />

subunits, and these subunits can be shared among different cytokines. This sharing of<br />

the receptor subunits among different cytokines may partially explain some of the functional<br />

redundancy and costimulation of their production and activity. The receptors can<br />

be grouped into four families according to similarities in their DNA or amino acid<br />

sequences: the cytokine receptor superfamily, the TNF superfamily, the immunoglobulin<br />

superfamily, and the IFN-R family.<br />

Most cytokine receptors are members of the cytokine receptor superfamily which is<br />

characterized by a conserved amino acid motif in the extracellular portion and in a<br />

region proximal to the membrane (9, 10). This superfamily can be divided into three<br />

subfamilies according to a shared subunit, i.e., those receptors that share the � chain,<br />

the gp 140 � chain, and the gp 130. The receptors in the � chain subfamily consist of<br />

three subunits (�, �, �): the �, and � subunits are members of the superfamily and are<br />

constitutively expressed on T-cells. Heterodimerization of the �� chains mediates signal<br />

transduction. The receptors <strong>for</strong> IL-13, IL-4, IL-7, IL-9, and IL-15 are members of<br />

this subfamily. An example of the sharing of the subunits of the cytokine receptor is<br />

the IL-2 receptor: IL-2R� is shared by IL-15, and IL-2R� is a subunit of the receptors<br />

<strong>for</strong> IL-4, IL-7, and IL-9. The subfamily of receptors that share the gp 140 � chain<br />

includes the receptors <strong>for</strong> IL-3, IL-5, and GM-CSF. Receptors in this subfamily have<br />

two subunits, with the � chain distinct <strong>for</strong> each receptor. Both the � and � chains are<br />

members of the cytokine receptor superfamily, and signaling is mediated through ligand<br />

interactions of the cytoplasmic regions on the shared � chain. The subfamily that<br />

shares gp 130 includes receptors <strong>for</strong> IL-6, IL-11, and IL-12. Formation of homodimers<br />

and heterodimers with gp 130 mediates signal transduction by these receptors.<br />

The TNF family of receptors includes two distinct receptors that bind TNF, TNFR-<br />

I (p75), and TNFR-II (p55). These receptors are homologous and bind both TNF-� and<br />

TNF-� with comparable affinity. Interestingly, other receptors in the TNF superfamily<br />

do not bind cytokines, e.g., FAS (CD95), which signals apoptosis of thymocytes (11)<br />

and CD40 ligand, which signals B-cell survival, proliferation, and switch in the Ig isotype<br />

(12). The immunoglobulin superfamily of receptors includes the two receptors <strong>for</strong><br />

IL-1 (13). Although both receptors bind IL-1 well, the type I receptor is the active moiety,<br />

and the type II receptor appears to have minimal activity. However, the type II<br />

receptor may be the precursor <strong>for</strong> soluble IL-1 receptor, which can bind IL-1 after<br />

being shed from the membrane. A newly described member of the IL-1 receptor family<br />

is the receptor <strong>for</strong> IL-18, which contains a binding and signaling chain that appears<br />

to share signal transduction pathways similar to those of IL-1R (14). Members of the<br />

IFN-R family include the receptors <strong>for</strong> IFN-�, IFN-�, and IL-10, which are distant<br />

members of the cytokine receptor superfamily. Investigation into the method of gene<br />

transcription through signal transduction from the IFN receptors has become a model<br />

<strong>for</strong> signal transduction by several cytokines, i.e., the Jak-Stat paradigm.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!